Phase 1 and 2 Study of PX-866 and Cetuximab

Clinical trial NCT01252628 · COMPLETED

Trial details

NCT number: NCT01252628
Sponsor: Cascadian Therapeutics Inc.
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Incurable Metastatic Colorectal Carcinoma Incurable Progressive, Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck

Start date: 2010-12-01
Primary completion: 2013-11-01
Enrollment: 178

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.